ADOC - Edoc Acquisition announces termination of deal with Calidi Biotherapeutics

• SPC Edoc Acquisition ( NASDAQ: ADOC ) announced the termination of its previously announced agreement and plan of merger with Calidi Biotherapeutics.
• In future both parties may continue to discuss the possibility of engaging in a business combination, there can be no assurance that those discussions will result in a transaction between Edoc and Calidi proceeding on the current terms of the Business Combination, if at all.
• As a result of the termination of the merger pact, Edoc intends to promptly begin simultaneously evaluating other possible business combination targets.

For further details see: